Pasithea Therapeutics (KTTA) EPS (Basic) (2021 - 2026)

Pasithea Therapeutics recorded quarterly EPS (Basic) of -$0.12 in Q1 2026, up 86.52% quarter-over-quarter from -$0.89 in Q4 2025, and up 92.55% year-over-year from -$0.06 in Q1 2025.

Pasithea Therapeutics' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.12 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 92.55% year-over-year to -$0.12; the TTM figure through Mar 2026 stood at -$2.08 (up 80.38% YoY), while the FY2025 annual figure was -$2.91, up 77.07% from the prior year.
  • EPS (Basic) came in at -$0.12 for Q1 2026 at Pasithea Therapeutics, up from -$0.89 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.01 in Q1 2022 to a low of -$9.24 in Q4 2022.
  • A 5-year average of -$2.27 and a median of -$2.41 in 2024 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) sank 25900.0% in 2023 and jumped 92.55% in 2026, its largest moves.
  • Pasithea Therapeutics' EPS (Basic) stood at -$9.24 in 2022, then soared by 51.19% to -$4.51 in 2023, then surged by 46.56% to -$2.41 in 2024, then surged by 63.07% to -$0.89 in 2025, then soared by 86.52% to -$0.12 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods registered -$0.12, -$0.89, and -$0.41 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 3.06
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 0.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 4.06
7 Evaxion A 64.16 Bn 64.14 Bn - 0.00
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 6.99
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.55
10 Pasithea Therapeutics 17.41 Mn 17.41 Mn - -0.12

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.12
Dec 31, 2025 -0.89
Sep 30, 2025 -0.41
Jun 30, 2025 -0.66
Mar 31, 2025 -1.61
Dec 31, 2024 -2.41
Sep 30, 2024 -2.87
Jun 30, 2024 -3.71
Mar 31, 2024 -3.70
Dec 31, 2023 -4.51
Sep 30, 2023 -2.87
Jun 30, 2023 -2.75
Mar 31, 2023 -2.60
Dec 31, 2022 -8.98
Sep 30, 2022 -0.16
Jun 30, 2022 -0.02
Mar 31, 2022 -0.01
Dec 31, 2021 0.12
Sep 30, 2021 -0.17
Jun 30, 2021 -0.09
Mar 31, 2021 -0.07